Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ABL1 | P00519 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | IDE | P14735 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | HLCS | P50747 | 6/20 | 0.51 |
| ▸ | CA12 | O43570 | 8/20 | 0.48 |
| ▸ | CA1 | P00915 | 8/20 | 0.48 |
| ▸ | CA2 | P00918 | 8/20 | 0.48 |
| ▸ | CA9 | Q16790 | 8/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3740873 | 0.92 | TDP1 (0.61) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL28780778 | 0.87 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL1215022 | 0.87 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL5503948 | 0.86 | TDP1 (0.76) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL2456558 | 0.86 | TDP1 (0.76) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL4433162 | 0.85 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL6648954 | 0.84 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL2847993 | 0.84 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL23055065 | 0.84 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL22943835 | 0.84 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119768425-A | Anti-TL 1A antibodies and methods of use thereof | 辉瑞大药厂 | 2025-04-04 | — | — | CN | disclosed |
| US-9523683-B2 | Functionalized polydiacetylene sensors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-12-20 | — | — | US | disclosed |
| US-20150268232-A1 | Functionalized Polydiacetylene Sensors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-09-24 | — | — | US | disclosed |
| US-8633140-B2 | Functionalized polydiacetylene sensors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-01-21 | — | — | US | disclosed |
| US-8318696-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2012-11-27 | — | — | US | disclosed |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | US | disclosed |
| US-7943595-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI-AVENTIS (FR) | 2011-05-17 | — | — | US | disclosed |
| US-20110059867-A1 | FUNCTIONALIZED POLYDIACETYLENE SENSORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2011-03-10 | — | — | US | disclosed |
| US-20060160768-A1 | Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2006-07-20 | — | — | US | disclosed |
| US-6844329-B2 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | SANOFI-SYNTHELABO (FR) | 2005-01-18 | — | — | US | disclosed |
| US-20040180381-A1 | Method for determining amino acid sequence of a peptide | SHIMADZU CORPORATION (JP) | 2004-09-16 | — | — | US | disclosed |
| US-20040024197-A1 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2004-02-05 | — | — | US | disclosed |
| EP-0817617-B1 | MICROCAPSULES OF PREDETERMINED PEPTIDE(S) SPECIFICITY(IES), THEIR PREPARATION AND USES | UNIV TEMPLE (US) | 2003-05-14 | — | — | EP | disclosed |
| EP-0817617-A4 | MICROCAPSULES OF PREDETERMINED PEPTIDE(S) SPECIFICITY(IES), THEIR PREPARATION AND USES | UNIV TEMPLE (US) | 1999-01-27 | — | — | EP | disclosed |
| EP-0817617-A1 | MICROCAPSULES OF PREDETERMINED PEPTIDE(S) SPECIFICITY(IES), THEIR PREPARATION AND USES | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5686113-A | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses | TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996029059-A9 | MICROCAPSULES OF PREDETERMINED PEPTIDE(S) SPECIFICITY(IES), THEIR PREPARATION AND USES | — | 1996-11-21 | — | — | WO | disclosed |
| WO-1996029059-A1 | MICROCAPSULES OF PREDETERMINED PEPTIDE(S) SPECIFICITY(IES), THEIR PREPARATION AND USES | TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1996-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160768-A1 | Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SERPINC1, SELP, FGB | TDP1 2935/4885MEN1 3047/4885ABL1 4875/4885 |
| US-20040180381-A1 | Method for determining amino acid sequence of a peptide | VIP, ANPEP, DNPEP | TDP1 2820/4885MEN1 940/4885ABL1 2829/4885 |
| US-20040024197-A1 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | SERPINC1, SELP, FGB | TDP1 2881/4885MEN1 2426/4885ABL1 4857/4885 |
| US-20110059867-A1 | FUNCTIONALIZED POLYDIACETYLENE SENSORS | STUB1, PA2G4, SUMO2 | TDP1 3652/4885MEN1 4390/4885ABL1 2213/4885 |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SERPINC1, SELP, FGB | TDP1 2935/4885MEN1 3047/4885ABL1 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.